+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
RhD Blood Grouping Reagent Kit Market by Form, Sales Channel, Product Type, Sample Type, Method, End User - Global Forecast to 2030- Product Image
RhD Blood Grouping Reagent Kit Market by Form, Sales Channel, Product Type, Sample Type, Method, End User - Global Forecast to 2030- Product Image
Sale

RhD Blood Grouping Reagent Kit Market by Form, Sales Channel, Product Type, Sample Type, Method, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 185 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6085373
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Setting the Stage for RhD Blood Grouping Innovation

The landscape of RhD blood grouping reagent kits has reached a pivotal juncture, underscored by continuous technological refinement and an unwavering emphasis on patient safety. As healthcare systems strive for greater precision in blood compatibility testing, reagent providers are confronted with the dual mandate of accelerating innovation while ensuring steadfast reliability under stringent regulatory scrutiny. This confluence of factors has elevated the RhD reagent segment from a routine laboratory supply to a strategic enabler of transfusion medicine and immunohematology.

Against this backdrop, stakeholders must navigate an intricate ecosystem that spans reagent formulation, manufacturing consistency, quality validation, and seamless distribution. Laboratory professionals demand workflows that minimize hands-on time and human error, while procurement executives balance budgetary constraints against the imperative for premium reagents and service support. Concurrently, regulatory bodies worldwide are harmonizing standards to bolster reagent traceability and performance, adding another layer of complexity to market entry and ongoing compliance.

This report opens with a holistic view of the drivers shaping the present moment in RhD blood grouping reagents. Through a careful examination of market forces, technological trajectories, and stakeholder expectations, the introduction sets the stage for deeper analysis of transformative shifts, tariff implications, segmentation insights, and strategic pathways that will define the competitive contours of this vital healthcare market.

Pioneering Transformations Shaping the RhD Reagent Market

The RhD reagent landscape is undergoing transformative shifts fueled by advances in reagent chemistry, automation, and data connectivity. Manufacturers are deploying novel conjugation techniques to enhance antigen-antibody specificity, thereby reducing false positives and improving sensitivity in serological assays. Concurrently, integration with automated platforms-from gel card processors to high-throughput microplate readers-is redefining laboratory workflows by delivering accelerated turnaround times and reproducible results with minimal manual intervention.

In parallel, digital transformation is altering how reagents are tracked, ordered, and managed. Cloud-based inventory systems now provide real-time visibility into stock levels, expiration dates, and lot traceability, enabling laboratories to fine-tune procurement cycles and cut waste. Such systems often interface directly with laboratory information management software, establishing a closed loop that spans reagent utilization, quality control logs, and regulatory reporting.

Beyond technological innovation, consolidation among suppliers and strategic partnerships between reagent developers and instrument manufacturers are reshaping the competitive landscape. Alliances aim to deliver end-to-end solutions, blending reagents, instrumentation, and software support under unified service agreements. This trend not only simplifies vendor management for healthcare providers but also accelerates the adoption of next-generation assays, ensuring that both emerging and established laboratories can seamlessly implement cutting-edge RhD testing protocols.

Assessing the 2025 US Tariff Wave on RhD Reagents

In 2025, the imposition of new United States tariffs on imported reagents has introduced significant headwinds for manufacturers and distributors alike. The additional duties have elevated landed costs for key raw materials and finished kits, prompting many suppliers to reassess their sourcing strategies. Some have accelerated localized production initiatives to mitigate import exposure, while others are renegotiating long-term contracts with overseas producers to secure tariff-inclusive pricing clauses.

These shifts have rippled downstream, as laboratories face steeper reagent budgets and tighter margins. Procurement teams are increasingly demanding cost transparency and exploring alternative reagent formats-such as lyophilized kits with extended shelf life-to reduce inventory turn over and buffer against future tariff volatility. At the same time, reagent developers are recalibrating their product portfolios, prioritizing core high-demand formats while deferring investment in niche assay variations that carry higher cross-border costs.

Regulatory compliance remains central to these adaptations. Companies relocating production or shifting supply chains must navigate FDA registration updates, quality system modifications, and potential delays in lot release approvals. In response, several forward-looking suppliers have established dual manufacturing sites, enabling agile production transfers and safeguarding continuity of supply even as tariff landscapes continue to evolve.

Unveiling Segmentation Dynamics Driving Market Nuances

Understanding market nuances requires a multifaceted segmentation approach that captures the diversity of reagent formats and end-user needs. When considering form, laboratories choose between ready-to-use liquid kits that streamline daily workflows and lyophilized reagents prized for stability in resource-limited settings. Sales channels further nuance the picture: direct engagements between manufacturers and large health systems coexist with distributor networks that serve regional laboratories, while online platforms-from proprietary manufacturer portals to third-party e-commerce marketplaces-offer added convenience and competitive pricing.

Product type segmentation reveals a shift toward monoclonal antibodies, favored for batch-to-batch consistency and specificity. Within this category, mouse-derived clones remain a mainstay, though recombinant monoclonal reagents are gaining traction for their scalable production and reduced risk of animal-sourced variability. In contrast, polyclonal reagents continue to fulfill certain diagnostic niches where broad antigen recognition is advantageous.

Sample type selection drives method preference: laboratories processing EDTA tubes-whether K2 or K3 anticoagulants-often leverage gel-based assays, including card-based gel systems and precast gel matrices, to achieve rapid agglutination reads. Serum, plasma, and whole blood specimens may also be subjected to microplate or tube agglutination protocols, depending on throughput demands and existing instrumentation. Finally, end-user environments vary from high-volume blood banks and diagnostic laboratories to hospital laboratories-both private and public-and specialized research institutes, each with distinct requirements for reagent performance, supply chain reliability, and technical support.

Mapping Regional Trends across Americas, EMEA, and Asia-Pacific

Regional dynamics in the RhD reagent market reflect varying healthcare infrastructures, regulatory environments, and demand patterns. In the Americas, established blood banking networks and widespread hospital consolidation drive stable demand for advanced reagent kits. Laboratories in the United States and Canada place a premium on rapid turnaround times and robust quality controls, creating a receptive environment for automated gel centrifugation systems and cloud-enabled inventory management solutions.

Across Europe, the Middle East, and Africa, disparate regulatory regimes and procurement practices shape a multifaceted marketplace. Western Europe’s mature diagnostics sector emphasizes alignment with In Vitro Diagnostic Regulation (IVDR) standards, while emerging markets in the Middle East and Africa focus on cost-effective reagent formats, such as lyophilized kits with extended shelf life and minimal cold-chain requirements. Cross-border trade within this region is influenced by harmonization initiatives and regional economic agreements.

In the Asia-Pacific region, robust investments in healthcare infrastructure and rising awareness of safe transfusion practices are catalyzing rapid uptake of new assays. Urban centers in China, Japan, and Australia demonstrate strong preference for monoclonal-based gel systems, while Southeast Asian and South Asian markets are increasingly served via distributor partnerships and online channels, ensuring broad reagent accessibility even in decentralized laboratory networks.

Profiling Leading Players in RhD Blood Grouping Solutions

The competitive arena for RhD blood grouping reagents is led by a handful of established diagnostics companies, each leveraging distinct strengths. Firms with integrated instrument and reagent portfolios offer seamless purchasing experiences, bundling software support and maintenance services that optimize assay performance. Others specialize in niche antibody development, focusing on recombinant monoclonal innovations that address rare antigen variants or enhanced shelf stability.

Strategic M&A activity has concentrated specialized reagent capabilities under larger diagnostics umbrellas, enabling cross-selling opportunities and expanded global distribution networks. Simultaneously, nimble startups are disrupting legacy supply chains with digital-first ordering platforms and direct-to-lab fulfillment models. Such players often excel at rapid customization-tailoring reagent panels for specific patient populations or emerging pathogen screening requirements.

Regardless of scale, leading suppliers prioritize regulatory compliance through proactive dossier maintenance, regular stability studies, and FDA or CE Mark expansions. Investments in local manufacturing and quality control centers abroad further fortify supply reliability, while dedicated technical application teams provide on-site training and ongoing service support. Together, these strategies underscore a market where innovation, agility, and regulatory excellence define leadership.

Strategic Imperatives for Industry Trailblazers

Industry leaders should accelerate development of recombinant monoclonal reagents to meet rising demand for consistency and scalability. Prioritizing partnerships with instrument manufacturers will facilitate bundled solutions that reduce implementation friction and deliver demonstrable value to laboratory directors. Expanding digital capabilities-particularly cloud-based inventory management and e-commerce portals-will strengthen customer loyalty and yield data insights that inform future product enhancements.

In anticipation of continued trade and tariff fluctuations, companies must diversify manufacturing footprints, establishing dual or multi-site production to ensure supply continuity. Cultivating relationships with regional distributors while offering direct-to-lab fulfillment options will address varying procurement preferences, especially in emerging markets. Moreover, integrating predictive analytics into supply chain planning can help stakeholders forecast demand shifts and mitigate inventory imbalances.

Finally, enhancing customer engagement through value-added services-such as competency training, rapid lot release programs, and remote technical assistance-will differentiate suppliers in a crowded marketplace. By combining technology-driven innovation with empathetic customer support, reagent providers can strengthen long-term partnerships and secure their positions as indispensable collaborators in transfusion medicine.

Rigorous Methodology Underpinning Robust Insights

This analysis is grounded in a robust research methodology that integrates primary and secondary data sources. Desk research encompassed a comprehensive review of peer-reviewed journals, regulatory filings, corporate whitepapers, and industry trade publications to establish foundational insights into reagent chemistry, assay platforms, and market trends. Concurrently, in-depth interviews were conducted with laboratory directors, procurement officers, and senior executives from leading reagent suppliers to validate market dynamics and capture real-world implementation challenges.

Secondary data were cross-referenced with company annual reports, patent databases, and tariff schedules to map the impact of policy changes on supply chain strategies. Segmentation analyses were informed by internal sales data, third-party distribution metrics, and laboratory information management system logs. Regional assessments leveraged public health statistics and healthcare expenditure data to contextualize demand patterns.

Data triangulation and rigorous quality checks ensured consistency across multiple information streams, while expert review panels provided critical validation at each stage. The resulting framework delivers an authoritative perspective on the RhD reagent market, offering decision-makers reliable, actionable insights supported by transparent methodologies and traceable data sources.

Synthesis of Core Insights and Market Direction

The RhD blood grouping reagent market stands at the confluence of technological innovation, regulatory evolution, and shifting trade dynamics. Advances in monoclonal antibody production, coupled with the increasing adoption of automated and digital solutions, are reshaping laboratory workflows and elevating performance standards. Simultaneously, the ripple effects of 2025 US tariffs have underscored the importance of diversified manufacturing footprints and agile supply chain strategies.

Segmentation analysis reveals nuanced preferences across form factors, sales channels, product types, sample types, assay methods, and end-user environments, highlighting the need for tailored offerings that align with specific laboratory priorities. Regional insights demonstrate contrasting adoption patterns-mature markets emphasize compliance with stringent regulations, emerging markets seek cost-effective stability, and high-growth regions invest heavily in next-generation platforms.

In this dynamic context, reagent providers must champion recombinant innovation, strategic partnerships, and digital engagement to maintain competitive momentum. By adhering to a disciplined, data-driven approach and embracing flexible manufacturing and distribution models, industry participants can not only withstand external shocks but also drive meaningful improvements in transfusion safety and diagnostic efficiency.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Form
    • Liquid
    • Lyophilized
  • Sales Channel
    • Direct Sales
    • Distributors
    • Online Channels
      • Manufacturer Website
      • Third Party E Commerce
  • Product Type
    • Monoclonal
      • Mouse Derived
      • Recombinant
    • Polyclonal
  • Sample Type
    • EDTA
      • K2 EDTA
      • K3 EDTA
    • Serum Plasma
    • Whole Blood
  • Method
    • Gel Centrifugation
      • Card Based Gel
      • Precast Gel
    • Microplate Agglutination
    • Tube Agglutination
  • End User
    • Blood Banks
    • Diagnostic Laboratories
    • Hospital Laboratories
      • Private Hospitals
      • Public Hospitals
    • Research Institutes
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Ortho Clinical Diagnostics, Inc.
  • Bio-Rad Laboratories, Inc.
  • Grifols, S.A.
  • Immucor, Inc.
  • Thermo Fisher Scientific Inc.
  • bioMérieux SA
  • Abbott Laboratories
  • Siemens Healthineers AG
  • Fresenius SE & Co. KGaA
  • Quotient Limited

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting

5. Market Dynamics

6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. RhD Blood Grouping Reagent Kit Market, by Form
8.1. Introduction
8.2. Liquid
8.3. Lyophilized

9. RhD Blood Grouping Reagent Kit Market, by Sales Channel
9.1. Introduction
9.2. Direct Sales
9.3. Distributors
9.4. Online Channels
9.4.1. Manufacturer Website
9.4.2. Third Party E Commerce

10. RhD Blood Grouping Reagent Kit Market, by Product Type
10.1. Introduction
10.2. Monoclonal
10.2.1. Mouse Derived
10.2.2. Recombinant
10.3. Polyclonal

11. RhD Blood Grouping Reagent Kit Market, by Sample Type
11.1. Introduction
11.2. EDTA
11.2.1. K2 EDTA
11.2.2. K3 EDTA
11.3. Serum Plasma
11.4. Whole Blood

12. RhD Blood Grouping Reagent Kit Market, by Method
12.1. Introduction
12.2. Gel Centrifugation
12.2.1. Card Based Gel
12.2.2. Precast Gel
12.3. Microplate Agglutination
12.4. Tube Agglutination

13. RhD Blood Grouping Reagent Kit Market, by End User
13.1. Introduction
13.2. Blood Banks
13.3. Diagnostic Laboratories
13.4. Hospital Laboratories
13.4.1. Private Hospitals
13.4.2. Public Hospitals
13.5. Research Institutes

14. Americas RhD Blood Grouping Reagent Kit Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina

15. Europe, Middle East & Africa RhD Blood Grouping Reagent Kit Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland

16. Asia-Pacific RhD Blood Grouping Reagent Kit Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan

17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Ortho Clinical Diagnostics, Inc.
17.3.2. Bio-Rad Laboratories, Inc.
17.3.3. Grifols, S.A.
17.3.4. Immucor, Inc.
17.3.5. Thermo Fisher Scientific Inc.
17.3.6. bioMérieux SA
17.3.7. Abbott Laboratories
17.3.8. Siemens Healthineers AG
17.3.9. Fresenius SE & Co. KGaA
17.3.10. Quotient Limited

18. ResearchAI

19. ResearchStatistics

20. ResearchContacts

21. ResearchArticles

22. Appendix

List of Figures
FIGURE 1. RHD BLOOD GROUPING REAGENT KIT MARKET MULTI-CURRENCY
FIGURE 2. RHD BLOOD GROUPING REAGENT KIT MARKET MULTI-LANGUAGE
FIGURE 3. RHD BLOOD GROUPING REAGENT KIT MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY FORM, 2024 VS 2030 (%)
FIGURE 8. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY SALES CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY SALES CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY METHOD, 2024 VS 2030 (%)
FIGURE 16. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 18. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. RHD BLOOD GROUPING REAGENT KIT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. RHD BLOOD GROUPING REAGENT KIT MARKET, FPNV POSITIONING MATRIX, 2024

List of Tables
TABLE 1. RHD BLOOD GROUPING REAGENT KIT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY LYOPHILIZED, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY MANUFACTURER WEBSITE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY THIRD PARTY E COMMERCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY ONLINE CHANNELS, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY MONOCLONAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY MOUSE DERIVED, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY MONOCLONAL, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY POLYCLONAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY EDTA, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY K2 EDTA, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY K3 EDTA, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY EDTA, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY SERUM PLASMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY GEL CENTRIFUGATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY CARD BASED GEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRECAST GEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY GEL CENTRIFUGATION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY MICROPLATE AGGLUTINATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY TUBE AGGLUTINATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY ONLINE CHANNELS, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY MONOCLONAL, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY EDTA, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY GEL CENTRIFUGATION, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY ONLINE CHANNELS, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY MONOCLONAL, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY EDTA, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY GEL CENTRIFUGATION, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 68. CANADA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 69. CANADA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 70. CANADA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY ONLINE CHANNELS, 2018-2030 (USD MILLION)
TABLE 71. CANADA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 72. CANADA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY MONOCLONAL, 2018-2030 (USD MILLION)
TABLE 73. CANADA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 74. CANADA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY EDTA, 2018-2030 (USD MILLION)
TABLE 75. CANADA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 76. CANADA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY GEL CENTRIFUGATION, 2018-2030 (USD MILLION)
TABLE 77. CANADA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. CANADA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 79. MEXICO RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 80. MEXICO RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 81. MEXICO RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY ONLINE CHANNELS, 2018-2030 (USD MILLION)
TABLE 82. MEXICO RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 83. MEXICO RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY MONOCLONAL, 2018-2030 (USD MILLION)
TABLE 84. MEXICO RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 85. MEXICO RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY EDTA, 2018-2030 (USD MILLION)
TABLE 86. MEXICO RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 87. MEXICO RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY GEL CENTRIFUGATION, 2018-2030 (USD MILLION)
TABLE 88. MEXICO RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 89. MEXICO RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY ONLINE CHANNELS, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY MONOCLONAL, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY EDTA, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY GEL CENTRIFUGATION, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY ONLINE CHANNELS, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY MONOCLONAL, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY EDTA, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY GEL CENTRIFUGATION, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY ONLINE CHANNELS, 2018-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY MONOCLONAL, 2018-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY EDTA, 2018-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY GEL CENTRIFUGATION, 2018-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 124. UNITED KINGDOM RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 125. UNITED KINGDOM RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 126. UNITED KINGDOM RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY ONLINE CHANNELS, 2018-2030 (USD MILLION)
TABLE 127. UNITED KINGDOM RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 128. UNITED KINGDOM RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY MONOCLONAL, 2018-2030 (USD MILLION)
TABLE 129. UNITED KINGDOM RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 130. UNITED KINGDOM RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY EDTA, 2018-2030 (USD MILLION)
TABLE 131. UNITED KINGDOM RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 132. UNITED KINGDOM RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY GEL CENTRIFUGATION, 2018-2030 (USD MILLION)
TABLE 133. UNITED KINGDOM RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 134. UNITED KINGDOM RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 135. GERMANY RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 136. GERMANY RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 137. GERMANY RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY ONLINE CHANNELS, 2018-2030 (USD MILLION)
TABLE 138. GERMANY RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 139. GERMANY RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY MONOCLONAL, 2018-2030 (USD MILLION)
TABLE 140. GERMANY RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 141. GERMANY RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY EDTA, 2018-2030 (USD MILLION)
TABLE 142. GERMANY RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 143. GERMANY RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY GEL CENTRIFUGATION, 2018-2030 (USD MILLION)
TABLE 144. GERMANY RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 145. GERMANY RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 146. FRANCE RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 147. FRANCE RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 148. FRANCE RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY ONLINE CHANNELS, 2018-2030 (USD MILLION)
TABLE 149. FRANCE RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 150. FRANCE RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY MONOCLONAL, 2018-2030 (USD MILLION)
TABLE 151. FRANCE RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 152. FRANCE RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY EDTA, 2018-2030 (USD MILLION)
TABLE 153. FRANCE RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 154. FRANCE RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY GEL CENTRIFUGATION, 2018-2030 (USD MILLION)
TABLE 155. FRANCE RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 156. FRANCE RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 157. RUSSIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY ONLINE CHANNELS, 2018-2030 (USD MILLION)
TABLE 160. RUSSIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 161. RUSSIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY MONOCLONAL, 2018-2030 (USD MILLION)
TABLE 162. RUSSIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 163. RUSSIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY EDTA, 2018-2030 (USD MILLION)
TABLE 164. RUSSIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 165. RUSSIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY GEL CENTRIFUGATION, 2018-2030 (USD MILLION)
TABLE 166. RUSSIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. RUSSIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 168. ITALY RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 169. ITALY RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 170. ITALY RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY ONLINE CHANNELS, 2018-2030 (USD MILLION)
TABLE 171. ITALY RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 172. ITALY RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY MONOCLONAL, 2018-2030 (USD MILLION)
TABLE 173. ITALY RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 174. ITALY RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY EDTA, 2018-2030 (USD MILLION)
TABLE 175. ITALY RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 176. ITALY RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY GEL CENTRIFUGATION, 2018-2030 (USD MILLION)
TABLE 177. ITALY RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 178. ITALY RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 179. SPAIN RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 180. SPAIN RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 181. SPAIN RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY ONLINE CHANNELS, 2018-2030 (USD MILLION)
TABLE 182. SPAIN RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 183. SPAIN RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY MONOCLONAL, 2018-2030 (USD MILLION)
TABLE 184. SPAIN RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 185. SPAIN RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY EDTA, 2018-2030 (USD MILLION)
TABLE 186. SPAIN RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 187. SPAIN RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY GEL CENTRIFUGATION, 2018-2030 (USD MILLION)
TABLE 188. SPAIN RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 189. SPAIN RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 190. UNITED ARAB EMIRATES RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 191. UNITED ARAB EMIRATES RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 192. UNITED ARAB EMIRATES RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY ONLINE CHANNELS, 2018-2030 (USD MILLION)
TABLE 193. UNITED ARAB EMIRATES RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 194. UNITED ARAB EMIRATES RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY MONOCLONAL, 2018-2030 (USD MILLION)
TABLE 195. UNITED ARAB EMIRATES RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 196. UNITED ARAB EMIRATES RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY EDTA, 2018-2030 (USD MILLION)
TABLE 197. UNITED ARAB EMIRATES RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 198. UNITED ARAB EMIRATES RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY GEL CENTRIFUGATION, 2018-2030 (USD MILLION)
TABLE 199. UNITED ARAB EMIRATES RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 200. UNITED ARAB EMIRATES RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 202. SAUDI ARABIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 203. SAUDI ARABIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY ONLINE CHANNELS, 2018-2030 (USD MILLION)
TABLE 204. SAUDI ARABIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 205. SAUDI ARABIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY MONOCLONAL, 2018-2030 (USD MILLION)
TABLE 206. SAUDI ARABIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 207. SAUDI ARABIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY EDTA, 2018-2030 (USD MILLION)
TABLE 208. SAUDI ARABIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 209. SAUDI ARABIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY GEL CENTRIFUGATION, 2018-2030 (USD MILLION)
TABLE 210. SAUDI ARABIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. SAUDI ARABIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 212. SOUTH AFRICA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 213. SOUTH AFRICA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 214. SOUTH AFRICA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY ONLINE CHANNELS, 2018-2030 (USD MILLION)
TABLE 215. SOUTH AFRICA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 216. SOUTH AFRICA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY MONOCLONAL, 2018-2030 (USD MILLION)
TABLE 217. SOUTH AFRICA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 218. SOUTH AFRICA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY EDTA, 2018-2030 (USD MILLION)
TABLE 219. SOUTH AFRICA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 220. SOUTH AFRICA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY GEL CENTRIFUGATION, 2018-2030 (USD MILLION)
TABLE 221. SOUTH AFRICA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. SOUTH AFRICA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 223. DENMARK RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 224. DENMARK RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 225. DENMARK RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY ONLINE CHANNELS, 2018-2030 (USD MILLION)
TABLE 226. DENMARK RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 227. DENMARK RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY MONOCLONAL, 2018-2030 (USD MILLION)
TABLE 228. DENMARK RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 229. DENMARK RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY EDTA, 2018-2030 (USD MILLION)
TABLE 230. DENMARK RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 231. DENMARK RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY GEL CENTRIFUGATION, 2018-2030 (USD MILLION)
TABLE 232. DENMARK RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 233. DENMARK RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 234. NETHERLANDS RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 235. NETHERLANDS RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 236. NETHERLANDS RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY ONLINE CHANNELS, 2018-2030 (USD MILLION)
TABLE 237. NETHERLANDS RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 238. NETHERLANDS RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY MONOCLONAL, 2018-2030 (USD MILLION)
TABLE 239. NETHERLANDS RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 240. NETHERLANDS RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY EDTA, 2018-2030 (USD MILLION)
TABLE 241. NETHERLANDS RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 242. NETHERLANDS RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY GEL CENTRIFUGATION, 2018-2030 (USD MILLION)
TABLE 243. NETHERLANDS RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 244. NETHERLANDS RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 245. QATAR RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 246. QATAR RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 247. QATAR RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY ONLINE CHANNELS, 2018-2030 (USD MILLION)
TABLE 248. QATAR RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 249. QATAR RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY MONOCLONAL, 2018-2030 (USD MILLION)
TABLE 250. QATAR RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 251. QATAR RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY EDTA, 2018-2030 (USD MILLION)
TABLE 252. QATAR RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 253. QATAR RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY GEL CENTRIFUGATION, 2018-2030 (USD MILLION)
TABLE 254. QATAR RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 255. QATAR RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 256. FINLAND RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 257. FINLAND RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 258. FINLAND RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY ONLINE CHANNELS, 2018-2030 (USD MILLION)
TABLE 259. FINLAND RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 260. FINLAND RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY MONOCLONAL, 2018-2030 (USD MILLION)
TABLE 261. FINLAND RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 262. FINLAND RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY EDTA, 2018-2030 (USD MILLION)
TABLE 263. FINLAND RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 264. FINLAND RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY GEL CENTRIFUGATION, 2018-2030 (USD MILLION)
TABLE 265. FINLAND RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 266. FINLAND RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 267. SWEDEN RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 268. SWEDEN RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 269. SWEDEN RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY ONLINE CHANNELS, 2018-2030 (USD MILLION)
TABLE 270. SWEDEN RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 271. SWEDEN RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY MONOCLONAL, 2018-2030 (USD MILLION)
TABLE 272. SWEDEN RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 273. SWEDEN RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY EDTA, 2018-2030 (USD MILLION)
TABLE 274. SWEDEN RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 275. SWEDEN RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY GEL CENTRIFUGATION, 2018-2030 (USD MILLION)
TABLE 276. SWEDEN RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 277. SWEDEN RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 278. NIGERIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 279. NIGERIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 280. NIGERIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY ONLINE CHANNELS, 2018-2030 (USD MILLION)
TABLE 281. NIGERIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 282. NIGERIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY MONOCLONAL, 2018-2030 (USD MILLION)
TABLE 283. NIGERIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 284. NIGERIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY EDTA, 2018-2030 (USD MILLION)
TABLE 285. NIGERIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 286. NIGERIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY GEL CENTRIFUGATION, 2018-2030 (USD MILLION)
TABLE 287. NIGERIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 288. NIGERIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 289. EGYPT RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 290. EGYPT RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 291. EGYPT RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY ONLINE CHANNELS, 2018-2030 (USD MILLION)
TABLE 292. EGYPT RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 293. EGYPT RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY MONOCLONAL, 2018-2030 (USD MILLION)
TABLE 294. EGYPT RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 295. EGYPT RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY EDTA, 2018-2030 (USD MILLION)
TABLE 296. EGYPT RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 297. EGYPT RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY GEL CENTRIFUGATION, 2018-2030 (USD MILLION)
TABLE 298. EGYPT RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 299. EGYPT RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 300. TURKEY RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 301. TURKEY RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 302. TURKEY RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY ONLINE CHANNELS, 2018-2030 (USD MILLION)
TABLE 303. TURKEY RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 304. TURKEY RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY MONOCLONAL, 2018-2030 (USD MILLION)
TABLE 305. TURKEY RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 306. TURKEY RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY EDTA, 2018-2030 (USD MILLION)
TABLE 307. TURKEY RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 308. TURKEY RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY GEL CENTRIFUGATION, 2018-2030 (USD MILLION)
TABLE 309. TURKEY RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 310. TURKEY RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 311. ISRAEL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 312. ISRAEL RHD BLOOD GROUPING

Companies Mentioned

The companies profiled in this RhD Blood Grouping Reagent Kit market report include:
  • Ortho Clinical Diagnostics, Inc.
  • Bio-Rad Laboratories, Inc.
  • Grifols, S.A.
  • Immucor, Inc.
  • Thermo Fisher Scientific Inc.
  • bioMérieux SA
  • Abbott Laboratories
  • Siemens Healthineers AG
  • Fresenius SE & Co. KGaA
  • Quotient Limited

Methodology

Loading
LOADING...

Related Topics

Related Reports

Blood-Grouping Reagents - Market Analysis, Forecast, Size, Trends and Insights - Product Image

Blood-Grouping Reagents - Market Analysis, Forecast, Size, Trends and Insights

  • Report
  • Global
From
Blood Group Typing Market Report 2025 - Product Image

Blood Group Typing Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Sterile Disposable Vacuum Blood Collection Tube Market by Product Type, Material, End User, Application, Sales Channel - Global Forecast to 2030 - Product Image

Sterile Disposable Vacuum Blood Collection Tube Market by Product Type, Material, End User, Application, Sales Channel - Global Forecast to 2030

  • Report
  • 188 Pages
  • Global
From
Blood Group Typing Market by Product Type, Technology, End User, Application - Global Forecast to 2030 - Product Image

Blood Group Typing Market by Product Type, Technology, End User, Application - Global Forecast to 2030

  • Report
  • 193 Pages
  • Global
From
Blood Transfusion Diagnostics Market Report 2025 - Product Image

Blood Transfusion Diagnostics Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.